T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Photronics
PLAB
$1.97B
| $397K | ﹤0.01% |
48,377
+100
| +0.2% | +$888 |
|
|
RESI
2202
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $396K | ﹤0.01% |
32,400
+100
| +0.3% | +$1.08K |
|
2203
BlackLine
BL
$1.82B
| $395K | ﹤0.01% |
+7,378
| New | +$367K |
|
2204
Stride
LRN
$3.48B
| $395K | ﹤0.01% |
12,997
+1,913
| +17% | +$61.6K |
|
|
NTUS
2205
DELISTED
Natus Medical Inc
NTUS
| $394K | ﹤0.01% |
15,320
-228,175
| -94% | -$5.81M |
|
|
WMC
2206
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $392K | ﹤0.01% |
3,931
+11
| +0.3% | +$1.12K |
|
|
AXE
2207
DELISTED
Anixter International Inc
AXE
| $392K | ﹤0.01% |
6,568
+90
| +1% | +$5.3K |
|
2208
Verastem
VSTM
$604M
| $390K | ﹤0.01% |
21,525
+17,731
| +467% | +$402K |
|
|
TELL
2209
DELISTED
Tellurian Inc.
TELL
| $389K | ﹤0.01% |
49,541
+470
| +1% | +$4.18K |
|
|
MCBC
2210
DELISTED
Macatawa Bank Corp
MCBC
| $389K | ﹤0.01% |
37,951
| – | – |
|
2211
First Community Bankshares
FCBC
$933M
| $388K | ﹤0.01% |
11,489
+30
| +0.3% | +$1.01K |
|
2212
Lexicon Pharmaceuticals
LXRX
$1.04B
| $388K | ﹤0.01% |
61,642
+26,900
| +77% | +$161K |
|
2213
Interface
TILE
$2.24B
| $387K | ﹤0.01% |
25,230
+132
| +0.5% | +$2.08K |
|
|
XOG
2214
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $387K | ﹤0.01% |
89,438
+458
| +0.5% | +$1.96K |
|
|
NGHC
2215
DELISTED
National General Holdings Corp
NGHC
| $387K | ﹤0.01% |
16,878
+187
| +1% | +$4.46K |
|
|
MOBL
2216
DELISTED
MobileIron, Inc.
MOBL
| $387K | ﹤0.01% |
62,377
+590
| +1% | +$3.34K |
|
|
GLUU
2217
DELISTED
Glu Mobile Inc.
GLUU
| $385K | ﹤0.01% |
53,615
+408
| +0.8% | +$3.75K |
|
2218
West Bancorporation
WTBA
$511M
| $383K | ﹤0.01% |
18,061
+46
| +0.3% | +$976 |
|
2219
Willis Lease Finance
WLFC
$1.15B
| $382K | ﹤0.01% |
19,665
| – | – |
|
|
DERM
2220
DELISTED
Dermira, Inc.
DERM
| $382K | ﹤0.01% |
39,968
+338
| +0.9% | +$3.64K |
|
2221
Rayonier Advanced Materials
RYAM
$570M
| $381K | ﹤0.01% |
58,703
+150
| +0.3% | +$1.56K |
|
|
UMH
2222
UMH Properties
UMH
$1.42B
| $381K | ﹤0.01% |
30,689
+6,938
| +29% | +$93.4K |
|
2223
Willdan Group
WLDN
$1.29B
| $379K | ﹤0.01% |
10,181
+24
| +0.2% | +$868 |
|
2224
GoPro
GPRO
$117M
| $375K | ﹤0.01% |
68,727
-23,408
| -25% | -$149K |
|
2225
NETGEAR
NTGR
$647M
| $375K | ﹤0.01% |
14,812
+100
| +0.7% | +$2.91K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.